The Immortality Experiment: Biotech Startup R3 Bio's Radical Vision for Human Cloning

R3 Bio's exposed agenda reveals how life-extension entrepreneurs are quietly pursuing human cloning and body replacement as avenues to immortality, marking a significant evolution in biotech ambitions. The stealth startup's partial public disclosure exposes the gap between corporate caution and the radical experiments funded by billionaires and specialized life-extension investors. This case is poised to intensify ethical and regulatory debates around human cloning and the technological feasibility of such transformative medical procedures.